Jia-Yan Kai, Zhi-Qi Ying, Xing-Xuan Dong, Carla Lanca, Andrzej Grzybowski, Xiao-Feng Zhang, Chen-Wei Pan
{"title":"Genetic Associations of Myopia and Axial Length with Diabetic Retinopathy.","authors":"Jia-Yan Kai, Zhi-Qi Ying, Xing-Xuan Dong, Carla Lanca, Andrzej Grzybowski, Xiao-Feng Zhang, Chen-Wei Pan","doi":"10.1080/09286586.2025.2546322","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the genetic associations of myopia and axial length (AL) with diabetic retinopathy (DR).</p><p><strong>Methods: </strong>We performed Mendelian randomization (MR) analyses using publicly available genome-wide association study (GWAS) summary statistics. Genetic variants were used as instrumental variables. Exposures included myopia, spherical equivalent (SE) and AL. Outcomes of interest included DR, its two subtypes including severe non-proliferative DR (NPDR) and proliferative DR (PDR), and vascular endothelial growth factor (VEGF) levels. The summary statistics for DR and its subtypes were derived from the FinnGen consortium, with over 20,000 participants involved.</p><p><strong>Results: </strong>A genetically predicted longer AL was significantly protective of PDR (per mm increase in AL: Odds ratio [OR], 0.77; 95% confidence interval [CI], 0.60 to 0.99). There were no significant causal associations of myopia, SE and AL with any DR or severe NPDR (<i>p</i> > 0.05 for all). After pooling the MR results from five different data sources, we found no evidence of causal relationship between AL and VEGF levels (beta, -0.01; 95% CI, -0.08 to 0.06).</p><p><strong>Conclusion: </strong>Our results suggest a possible causal relationship between an increased AL and a reduced risk of PDR, which may provide insights into novel strategies to prevent PDR.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-9"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2025.2546322","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To investigate the genetic associations of myopia and axial length (AL) with diabetic retinopathy (DR).
Methods: We performed Mendelian randomization (MR) analyses using publicly available genome-wide association study (GWAS) summary statistics. Genetic variants were used as instrumental variables. Exposures included myopia, spherical equivalent (SE) and AL. Outcomes of interest included DR, its two subtypes including severe non-proliferative DR (NPDR) and proliferative DR (PDR), and vascular endothelial growth factor (VEGF) levels. The summary statistics for DR and its subtypes were derived from the FinnGen consortium, with over 20,000 participants involved.
Results: A genetically predicted longer AL was significantly protective of PDR (per mm increase in AL: Odds ratio [OR], 0.77; 95% confidence interval [CI], 0.60 to 0.99). There were no significant causal associations of myopia, SE and AL with any DR or severe NPDR (p > 0.05 for all). After pooling the MR results from five different data sources, we found no evidence of causal relationship between AL and VEGF levels (beta, -0.01; 95% CI, -0.08 to 0.06).
Conclusion: Our results suggest a possible causal relationship between an increased AL and a reduced risk of PDR, which may provide insights into novel strategies to prevent PDR.
期刊介绍:
Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.